Abstract
Cardiovascular disease (CVD) is the leading cause of death globally and disproportionately affects low-income and middle-income countries. Dyslipidaemia is an important modifiable risk factor for CVD. There are important knowledge gaps regarding the population levels of lipid variables and frequency of non-optimal levels in populations within Africa. We propose to conduct a systematic review to determine the prevalence and occurrence of dyslipidaemia in adult populations within countries in Africa. We will perform a comprehensive search to identify all possible published and unpublished studies on the prevalence or incidence of dyslipidaemia in Africa reported from 1 January 1980, without language restriction. The scientific databases PubMed MEDLINE, EMBASE and ISI Web of Science will be searched, as well as Grey literature. Following study selection, full-text papers acquisition, and data extraction and synthesis, we will appraise the quality of studies and risk of bias, and assess heterogeneity. Prevalence/incidence data will be summarised by country and geographic regions and a meta-analysis will be conducted for variables defined identically across studies. Variance stabilising transformations will be applied as appropriate...Continue Reading
References
Feb 5, 1994·BMJ : British Medical Journal·M R LawS G Thompson
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
May 2, 2000·JAMA : the Journal of the American Medical Association·D F StroupS B Thacker
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Jul 14, 2004·Circulation·Scott M GrundyUNKNOWN American Heart Association
Sep 11, 2004·Journal of the American College of Cardiology·Scott M GrundyUNKNOWN Coordinating Committee of the National Cholesterol Education Program
Sep 15, 2004·Lancet·Salim YusufUNKNOWN INTERHEART Study Investigators
Nov 16, 2005·Journal of the American College of Cardiology·Jennifer G RobinsonHelmut Schrott
Feb 17, 2007·Lancet Neurology·Myles D ConnorCharles P Warlow
Oct 19, 2007·PLoS Medicine·Erik von ElmUNKNOWN STROBE Initiative
Oct 24, 2007·Preventive Medicine·Erik von ElmUNKNOWN STROBE Initiative
Nov 12, 2010·Lancet·UNKNOWN Cholesterol Treatment Trialists’ (CTT) CollaborationR Collins
Nov 30, 2010·CVD Prevention and Control·Anne E SumnerCharles N Rotimi
Oct 28, 2011·Public Health·A Mitchell, T Voon
May 23, 2012·Lancet·Benjamin F VoightSekar Kathiresan
Jun 30, 2012·Journal of Clinical Epidemiology·Damian HoyRachelle Buchbinder
Jul 17, 2012·JAMA : the Journal of the American Medical Association·Emanuele Di AngelantonioJohn Danesh
Jul 24, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·P I BurgessP Garner
Aug 22, 2013·Journal of Epidemiology and Community Health·Jan J BarendregtTheo Vos
Nov 14, 2013·Circulation·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Aug 12, 2014·The Lancet Global Health·John W StaniferUptal Patel
Jan 3, 2015·Systematic Reviews·David MoherUNKNOWN PRISMA-P Group
Citations
Feb 9, 2016·Foodborne Pathogens and Disease·Miao GuoAbani K Pradhan
Jun 23, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Chengyi DingSiyan Zhan
Dec 11, 2019·The Analyst·Kyu Shik EomSoo Hyun Lee
Jul 1, 2018·JMIR Research Protocols·Poobalan NaidooDirk Jacobus Blom
May 24, 2020·International Journal of Environmental Research and Public Health·Timotheus B Darikwa, Samuel O Manda
Jul 6, 2019·BMC Public Health·Soheir H AhmedAhmed A Madar
Jul 9, 2021·Drug Metabolism and Personalized Therapy·Mohd Aleemuddin QuamriBarkat Farooqui Ali